No Street GP LP’s Ginkgo Bioworks DNA Stock Holding History

No Street GP LP’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,000	Closed	-$9.36M	–	28
2022 Q3	$9.36M	Buy	+75,000	New	+$8.94M	1.47%	25

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

No Street GP LP's DNA Position: Q4 2022 in Review

No Street GP LP sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 75,000 shares — an estimated $9.36M sold.

No Street GP LP first reported a position in DNA in Q3 2022 and held it in 1 quarter. The position peaked at $9.36M in Q3 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

No Street GP LP reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
No Street GP LP sold 75,000 Ginkgo Bioworks shares in Q4 2022, an estimated $9.36M.
No Street GP LP first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 1 quarter.
No Street GP LP's Ginkgo Bioworks position peaked at $9.36M in Q3 2022.
320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on No Street GP LP's 13F filing for Q4 2022, filed 14 Feb 2023.